跳至主要内容
临床试验/IRCT201111291414N28
IRCT201111291414N28已完成早期 1 期

Investigation on autologous mesenchymal stem cell transplantation in diabetic nephrophaty (type one)

Endocrinology and Metabolism Research Institute (EMRI)0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
All

入选标准

  • 1.signing informed consent
  • 2.People with diabetes type one with at least 10 years duration
  • 3.age 18-40 years
  • 4.Diabetic nephropathy diagnosed by nephrologists
  • 5.HbA1c = 7.5% (blood glucose is controlled at least for one month)
  • Exclusion criteria:
  • 1.acute vascular inflammation
  • 2.acute thrombosis (three months)
  • 3. recent bleeding in the retina (the last three months)
  • 4. pulmonary hypertension
  • 5. liver disease
  • 6. tumors in bone marrow or any malignancy is diagnosed
  • 7.infectious diseases
  • 8.mental illness
  • 9. generalized edema
  • 10. malignancy
  • 11.pregnancy
  • 12.Diastolic blood pressure =110
  • 13. Cigar Smoker

排除标准

  • 未提供

研究者

发起方
Endocrinology and Metabolism Research Institute (EMRI)

相似试验

Investigation on autologous mesenchymal stem cell... | 临床试验